[HTML][HTML] Early outpatient treatment for Covid-19 with convalescent plasma

…, B Lau, AG Shenoy, GS Mosnaim… - … England Journal of …, 2022 - Mass Medical Soc
Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …

Work group report: COVID-19: unmasking telemedicine

…, Q Rashid, MR Rupp, J Shih, GS Mosnaim - The Journal of Allergy …, 2020 - Elsevier
Telemedicine adoption has rapidly accelerated since the onset of the COVID-19 pandemic.
Telemedicine provides increased access to medical care and helps to mitigate risk by …

[HTML][HTML] Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

…, LL Hammitt, S Kassaye, GS Mosnaim… - The Lancet …, 2023 - thelancet.com
Background Cytokines and chemokines play a critical role in the response to infection and
vaccination. We aimed to assess the longitudinal association of COVID-19 vaccination with …

[HTML][HTML] Randomized controlled trial of early outpatient COVID-19 treatment with high-titer convalescent plasma

…, EM Bloch, B Lau, AG Shenoy, GS Mosnaim… - Medrxiv, 2021 - ncbi.nlm.nih.gov
BACKGROUND: The efficacy of polyclonal high titer convalescent plasma to prevent
serious complications of COVID-19 in outpatients with recent onset of illness is uncertain. …

The impact of patient self-monitoring via electronic medication monitor and mobile app plus remote clinician feedback on adherence to inhaled corticosteroids: a …

GS Mosnaim, DA Stempel, C Gonzalez… - The Journal of Allergy …, 2021 - Elsevier
Background Poor adherence to inhaled corticosteroids (ICSs) and overuse of short-acting
beta 2 -agonists (SABAs) are associated with increased asthma morbidity. Objective To …

The One Health approach for allergic diseases and asthma

M Jutel, GS Mosnaim, JA Bernstein, S Del Giacco… - Allergy, 2023 - Wiley Online Library
The One Health approach is a collaborative and interdisciplinary strategy with focal point on
human, animal, and environmental health interconnections. One Health can support the …

[HTML][HTML] Effectiveness of a digital inhaler system for patients with asthma: a 12-week, open-label, randomized study (CONNECT1)

FCL Hoyte, GS Mosnaim, L Rogers, G Safioti… - The Journal of Allergy …, 2022 - Elsevier
… Author links open overlay panel Flavia CL Hoyte MD a , Giselle S. Mosnaim MD, MS b ,
Linda Rogers MD c , Guilherme Safioti MD d , Randall Brown MD, MPH e , Thomas Li PhD e , …

Family chaos and asthma control

SM Weinstein, O Pugach, G Rosales, GS Mosnaim… - …, 2019 - publications.aap.org
OBJECTIVES: Asthma is a highly prevalent childhood chronic disease, with particularly high
rates among poor and minority youth. Psychosocial factors have been linked to asthma …

Behavioral interventions to improve asthma outcomes for adolescents: a systematic review

GS Mosnaim, AA Pappalardo, SE Resnick… - The Journal of Allergy …, 2016 - Elsevier
… Author links open overlay panel Giselle S. Mosnaim MD, MS a , Andrea A. Pappalardo
MD … Mosnaim et al 28 , ‡ 28, Range 10-18 yo Celebrity asthma messages General health …

Early antibody treatment, inflammation, and risk of post-COVID conditions

…, LL Hammitt, MA Huaman, A Levine, GS Mosnaim… - Mbio, 2023 - Am Soc Microbiol
Post-COVID conditions (PCCs) are common and have significant morbidity. Risk factors for
PCC include advancing age, female sex, obesity, and diabetes mellitus. Little is known about …